Literature DB >> 2544224

The role of surgery in metastatic testicular germ cell tumours (GCT).

E S Newlands1, K W Reynolds.   

Abstract

Entities:  

Mesh：

Year:  1989        PMID： 2544224      PMCID： PMC2246725          DOI： 10.1038/bjc.1989.177

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  10 in total

1.  Current optimum management of anaplastic germ cell tumours of the testis and other sites.

Authors:  E S Newlands; K D Bagshawe; R H Begent; G J Rustin; S M Crawford; L Holden
Journal:  Br J Urol       Date:  1986-06

2.  Immediate adjuvant chemotherapy versus observation with treatment at relapse in pathological stage II testicular cancer.

Authors:  S D Williams; D M Stablein; L H Einhorn; F M Muggia; R B Weiss; J P Donohue; D F Paulson; K W Brunner; E M Jacobs; J T Spaulding
Journal:  N Engl J Med       Date:  1987-12-03       Impact factor: 91.245

3.  Epipodophylin derivative (VP 16-23) in malignant teratomas and choriocarcinomas.

Authors:  E S Newlands; K D Bagshawe
Journal:  Lancet       Date:  1977-07-09       Impact factor: 79.321

4.  Retroperitoneal lymphadenectomy and aggressive chemotherapy in nonbulky clinical Stage II nonseminomatous germinal testis tumors.

Authors:  G Pizzocaro; F Zanoni; A Milani; L Piva; R Salvioni; M Pasi; S Pilotti; S Monfardini
Journal:  Cancer       Date:  1984-03-15       Impact factor: 6.860

5.  Effects of multiple-drug chemotherapy (cis-diammine-dichloroplatinum, bleomycin, and vinblastine) on the maturation of retroperitoneal lymph node metastases of nonseminomatous germ cell tumors of the testis. No evidence for De Novo induction of differentiation.

Authors:  J W Oosterhuis; A J Suurmeyer; D T Sleyfer; H S Koops; J Oldhoff; G Fleuren
Journal:  Cancer       Date:  1983-02-01       Impact factor: 6.860

6.  Cis-diamminedichloroplatinum, vinblastine, and bleomycin combination chemotherapy in disseminated testicular cancer.

Authors:  L H Einhorn; J Donohue
Journal:  Ann Intern Med       Date:  1977-09       Impact factor: 25.391

7.  A randomized trial of cytoreductive surgery followed by chemotherapy versus chemotherapy alone in bulky stage testicular cancer with poor prognostic features.

Authors:  N Javadpour; R F Ozols; T Anderson; A B Barlock; R Wesley; R C Young
Journal:  Cancer       Date:  1982-11-15       Impact factor: 6.860

8.  Treatment of disseminated germ-cell tumors with cisplatin, bleomycin, and either vinblastine or etoposide.

Authors:  S D Williams; R Birch; L H Einhorn; L Irwin; F A Greco; P J Loehrer
Journal:  N Engl J Med       Date:  1987-06-04       Impact factor: 91.245

9.  The effect of intensity of administered treatment on the outcome of germ cell tumours treated with POMB/ACE chemotherapy.

Authors:  S M Crawford; E S Newlands; R H Begent; G J Rustin; K D Bagshawe
Journal:  Br J Cancer       Date:  1989-02       Impact factor: 7.640

10.  Post-chemotherapy surgery in advanced non-seminomatous germ-cell testicular tumours: the significance of histology with particular reference to differentiated (mature) teratoma.

Authors:  D Tait; M J Peckham; W F Hendry; P Goldstraw
Journal:  Br J Cancer       Date:  1984-11       Impact factor: 7.640
  10 in total
  1 in total

1.  Prognosis after resection of residual masses following chemotherapy for metastatic nonseminomatous testicular cancer: a multivariate analysis.

Authors:  E W Steyerberg; H J Keizer; J Zwartendijk; G L Van Rijk; C J Van Groeningen; J D Habbema; G Stoter
Journal:  Br J Cancer       Date:  1993-07       Impact factor: 7.640
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.